An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Adherence to regulatory guidelines is essential to ensure its responsible and effective use
Additionally, common medications can be NET inhibitors, such as some tricyclic antidepressants and certain ADHD medications.[ref] Medications that impact NET may be helpful in POTS
In patients on GLP-1 RAs, it is even more likely that gastric emptying of high-calorie content liquids is delayed, as shown by our literature review
Diabetes Metab J 44(6):80218 Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS et al (2022) LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept